ARS Pharmaceuticals, Inc. (SPRY) income statement
SPRYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.96−0.40 (-11.90%)
Close on Nov 20, 2026Market cap $294.36MP/E –Yield –
ARS Pharmaceuticals, Inc. financial ratios
See a number that looks wrong?